Mesoblast (MEOBF) Invested Capital (2017 - 2025)

Mesoblast (MEOBF) has disclosed Invested Capital for 9 consecutive years, with $121.9 million as the latest value for Q2 2025.

  • Quarterly Invested Capital rose 6.6% to $121.9 million in Q2 2025 from the year-ago period, while the trailing twelve-month figure was $593.7 million through Jun 2022, down 6.45% year-over-year, with the annual reading at $121.9 million for FY2025, 6.6% up from the prior year.
  • Invested Capital hit $121.9 million in Q2 2025 for Mesoblast, up from $114.3 million in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $634.6 million in Q2 2021 to a low of $108.8 million in Q2 2023.
  • Historically, Invested Capital has averaged $314.7 million across 5 years, with a median of $121.9 million in 2025.
  • Biggest five-year swings in Invested Capital: increased 9.08% in 2021 and later plummeted 81.68% in 2023.
  • Year by year, Invested Capital stood at $634.6 million in 2021, then dropped by 6.45% to $593.7 million in 2022, then tumbled by 81.68% to $108.8 million in 2023, then increased by 5.13% to $114.3 million in 2024, then rose by 6.6% to $121.9 million in 2025.
  • Business Quant data shows Invested Capital for MEOBF at $121.9 million in Q2 2025, $114.3 million in Q2 2024, and $108.8 million in Q2 2023.